Two Sigma Investments’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13M Buy
53,253
+22,894
+75% +$5.33M 0.01% 1234
2025
Q4
$6.28M Sell
30,359
-894,928
-97% -$177M 0.01% 1506
2025
Q3
$172M Buy
925,287
+748,295
+423% +$128M 0.26% 105
2025
Q2
$27M Buy
176,992
+153,035
+639% +$23.5M 0.05% 446
2025
Q1
$3.97M Sell
23,957
-39,811
-62% -$6.23M 0.01% 1247
2024
Q4
$9.22M Buy
+63,768
New +$9.88M 0.02% 794
2024
Q3
Sell
-649,754
Closed -$95M 3233
2024
Q2
$95M Buy
649,754
+304,943
+88% +$45.4M 0.22% 110
2024
Q1
$54.5M Sell
344,811
-678,031
-66% -$108M 0.13% 196
2023
Q4
$160M Buy
1,022,842
+1,016,086
+15,040% +$156M 0.37% 55
2023
Q3
$1.05M Sell
6,756
-744,052
-99% -$123M ﹤0.01% 1901
2023
Q2
$124M Sell
750,808
-366,440
-33% -$59.1M 0.31% 77
2023
Q1
$173M Sell
1,117,248
-214,408
-16% -$34.6M 0.5% 30
2022
Q4
$235M Buy
1,331,656
+3,836
+0.3% +$662K 0.74% 13
2022
Q3
$217M Buy
1,327,820
+557,838
+72% +$94.4M 0.74% 15
2022
Q2
$137M Buy
769,982
+210,314
+38% +$37.5M 0.45% 46
2022
Q1
$99.2M Sell
559,668
-948,637
-63% -$161M 0.29% 83
2021
Q4
$258M Buy
1,508,305
+691,361
+85% +$113M 0.55% 7
2021
Q3
$132M Sell
816,944
-681,654
-45% -$116M 0.29% 81
2021
Q2
$247M Sell
1,498,598
-135,944
-8% -$22.5M 0.56% 10
2021
Q1
$269M Buy
1,634,542
+895,829
+121% +$145M 0.7% 2
2020
Q4
$116M Buy
738,713
+347,268
+89% +$51.2M 0.33% 69
2020
Q3
$58.3M Buy
391,445
+376,318
+2,488% +$55.7M 0.21% 115
2020
Q2
$2.13M Buy
+15,127
New +$2.2M 0.01% 1065
2020
Q1
Sell
-1,325,576
Closed -$193M 3479
2019
Q4
$193M Sell
1,325,576
-215,505
-14% -$29.2M 0.58% 19
2019
Q3
$199M Buy
1,541,081
+259,313
+20% +$34.2M 0.67% 7
2019
Q2
$179M Buy
1,281,768
+1,247,510
+3,642% +$173M 0.6% 7
2019
Q1
$4.79M Sell
34,258
-121,791
-78% -$16.3M 0.02% 987
2018
Q4
$20.1M Sell
156,049
-724,175
-82% -$101M 0.08% 331
2018
Q3
$122M Sell
880,224
-472,649
-35% -$62.8M 0.33% 66
2018
Q2
$164M Buy
1,352,873
+1,059,615
+361% +$132M 0.49% 17
2018
Q1
$37.6M Buy
293,258
+290,346
+9,971% +$39.2M 0.13% 201
2017
Q4
$407K Buy
2,912
+977
+50% +$136K ﹤0.01% 2570
2017
Q3
$252K Sell
1,935
-94,102
-98% -$12.5M ﹤0.01% 2504
2017
Q2
$12.7M Buy
96,037
+84,181
+710% +$10.7M 0.05% 440
2017
Q1
$1.48M Sell
11,856
-11,779
-50% -$1.41M 0.01% 1647
2016
Q4
$2.72M Buy
+23,635
New +$2.73M 0.01% 1253
2016
Q3
Sell
-26,273
Closed -$3.19M 3235
2016
Q2
$3.19M Sell
26,273
-502,612
-95% -$57.1M 0.01% 998
2016
Q1
$57.2M Buy
+528,885
New +$54.8M 0.27% 81
2015
Q4
Sell
-1,381,870
Closed -$139M 2823
2015
Q3
$129M Buy
1,381,870
+220,722
+19% +$21.4M 0.66% 30
2015
Q2
$113M Sell
1,161,148
-431,639
-27% -$43.2M 0.53% 22
2015
Q1
$160M Buy
1,592,787
+1,586,463
+25,086% +$161M 0.75% 5
2014
Q4
$661K Sell
6,324
-1,499,511
-100% -$158M ﹤0.01% 1583
2014
Q3
$161M Buy
1,505,835
+1,415,725
+1,571% +$147M 0.72% 7
2014
Q2
$9.43M Buy
+90,110
New +$9.11M 0.04% 506
2014
Q1
Sell
-1,139,829
Closed -$104M 2125
2013
Q4
$104M Sell
1,139,829
-715,607
-39% -$65.9M 0.58% 22
2013
Q3
$161M Buy
+1,855,436
New +$166M 1.03% 2

Other funds holding JNJ

Two Sigma Investments's JNJ Position: Q1 2026 in Review

Two Sigma Investments increased its Johnson & Johnson (JNJ) stake by 75% in Q1 2026, buying an estimated $5.33M and bringing the position to 53,253 shares worth $13M. The position accounts for 0.01% of the portfolio, ranked #1234.

Two Sigma Investments first reported a position in JNJ in Q3 2013 and has held it in 46 quarters since. The position peaked at $269M in Q1 2021. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Two Sigma Investments held 53,253 shares of Johnson & Johnson worth $13M as of Q1 2026.
  • Two Sigma Investments bought 22,894 Johnson & Johnson shares in Q1 2026, an estimated $5.33M.
  • Johnson & Johnson made up 0.01% of Two Sigma Investments's portfolio in Q1 2026, its #1234 holding.
  • Two Sigma Investments first reported a position in Johnson & Johnson in Q3 2013 and has held it in 46 quarters since.
  • Two Sigma Investments's Johnson & Johnson position peaked at $269M in Q1 2021.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.